Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study (Q33590146)

28 July 2017

title

Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study (English)

1 reference

chronic progressive multiple sclerosis

28 July 2017

0 references

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1136/JNNP.54.12.1055

22 November 2022

author name string

W. H. Likosky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783915

22 November 2022

B. Fireman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783915

22 November 2022

R. Elmore

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783915

22 November 2022

G. Eno

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783915

22 November 2022

K. Gale

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783915

22 November 2022

G. B. Goode

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783915

22 November 2022

K. Ikeda

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783915

22 November 2022

J. Laster

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783915

22 November 2022

C. Mosher

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783915

22 November 2022

J. Rozance

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783915

22 November 2022

language of work or name

English

0 references

publication date

1 December 1991

1 reference

full work available at URL

28 July 2017

https://europepmc.org/articles/PMC1014677

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783915

https://europepmc.org/articles/PMC1014677?pdf=render

22 November 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1783915

https://syndication.highwire.org/content/doi/10.1136/jnnp.54.12.1055

22 November 2022

1 reference

Crossref

https://api.crossref.org/works/10.1136/JNNP.54.12.1055

Journal of Neurology, Neurosurgery and Psychiatry

22 November 2022

published in

1 reference

28 July 2017

volume

54

1 reference

28 July 2017

issue

12

1 reference

28 July 2017

page(s)

1055-1060

1 reference

Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014677

Gonadal dysfunction in patients receiving chemotherapy for cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014677

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014677

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014677

Multiple sclerosis (second of two parts).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014677

Immunodepressive therapy in neurology

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014677

Overview of the rationale for immunomodulating therapies in multiple sclerosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014677

Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014677

Pathology of multiple sclerosis: progression of the lesion

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014677

Cyclophosphamide and malignancy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014677

Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014677

[Multiple sclerosis and the autoimmunization process. Treatment by antimitotics]

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014677

Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients

31 October 2018

1 reference

12 December 2020

Cyclophosphamide 'pulses' in chronic progressive multiple sclerosis. A preliminary clinical trial

1 reference

12 December 2020

Effect of intensive immunosuppression on the course of chronic progressive multiple sclerosis

1 reference

12 December 2020

Cyclophosphamide in multiple sclerosis

1 reference

12 December 2020

Corticotrophin treatment in multiple sclerosis

1 reference

12 December 2020

Correlation of clinical and immunologic states in multiple sclerosis

1 reference

12 December 2020

Future directions: where do we go from here?

7

1 reference

Crossref

https://api.crossref.org/works/10.1136/JNNP.54.12.1055

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

22 November 2022

22

1 reference

Crossref

https://api.crossref.org/works/10.1136/JNNP.54.12.1055

22 November 2022

Identifiers

1 reference

28 July 2017

1 reference

28 July 2017

1 reference